hotspot -WSS

hotspot

author：fashion 2025-09-06 02:04:05 - browse：562

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： The new shift in health care is toward less care

WSS

More doctors should go into startup world

White House calls on federal agencies to crack down on AI abuses

A clever new way to fix Medicaid and graduate medical education

Extreme heat events are a public health emergency

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

hotspot

hotspot

explore

Wildfire smoke exposes gaps in outdoor worker protections

Steward Health Care Massachusetts hospitals face fiscal disaster

Hollywood unions extend contract negotiations for actors

Ebola: Gilead Sciences antiviral shows promise as new treatment

Jerome Adams on the need for new antivirals for Covid

Will General Catalyst be the first of many hospital takeovers?

23andMe had bad news about my health. I wish a person had delivered it

Abortion clinic in Cancun will cater to Americans

Virginia high school admissions case could be legal follow

White House calls on federal agencies to crack down on AI abuses

leisure time

RaDonda Vaught links Vanderbilt hospital issues to patient death

Diversify hospital leadership teams to protect BIPOC patient health

Abortion clinic in Cancun will cater to Americans

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Amid AI frenzy, a top HHS official's quest to create safeguards

Boston's new lab space is opening empty

explore

focus

entertainment

hotspot